87 related articles for article (PubMed ID: 32160650)
21. LncRNA MIR155HG functions as a ceRNA for inhibition of lung adenocarcinoma growth and prediction of prognosis.
Wang J; Li J
Arch Med Sci; 2024; 20(2):539-556. PubMed ID: 38757039
[TBL] [Abstract][Full Text] [Related]
22. The long non-coding RNAs (lncRNA) in the pathogenesis of gastric cancer cells: molecular mechanisms and involvement miRNAs.
Saleh RO; Al-Hawary SIS; Hammoud A; Hjazi A; Ayad Abdulrazzaq S; Rajput P; Alawsi T; Alnajar MJ; Alawadi A
Mol Biol Rep; 2024 May; 51(1):615. PubMed ID: 38704760
[TBL] [Abstract][Full Text] [Related]
23. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
Zabeti Touchaei A; Vahidi S; Samadani AA
Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
[TBL] [Abstract][Full Text] [Related]
24. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
[TBL] [Abstract][Full Text] [Related]
25. A reliable mouse model of liver and lung metastasis by injecting esophageal cancer stem cells (CSCs) through tail-vein injection.
Kokabi F; Khosravi A; Jazi MS; Asadi J
Mol Biol Rep; 2023 Apr; 50(4):3401-3411. PubMed ID: 36753017
[TBL] [Abstract][Full Text] [Related]
26. Regulation of autophagy by non-coding RNAs in gastric cancer.
Wang Z; Liu J; Xie J; Yuan X; Wang B; Shen W; Zhang Y
Front Oncol; 2022; 12():947332. PubMed ID: 36353541
[TBL] [Abstract][Full Text] [Related]
27. The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer.
Yang Y; Meng WJ; Wang ZQ
Front Oncol; 2022; 12():960539. PubMed ID: 36185219
[TBL] [Abstract][Full Text] [Related]
28. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
Front Public Health; 2022; 10():898270. PubMed ID: 35874989
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analysis of potential Key lncRNA-miRNA-mRNA molecules as prognostic markers and important ceRNA axes in gastric cancer.
Tang S; Liao K; Shi Y; Tang T; Cui B; Huang Z
Am J Cancer Res; 2022; 12(5):2397-2418. PubMed ID: 35693096
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer.
Liu Y; Ding W; Yu W; Zhang Y; Ao X; Wang J
Mol Ther Oncolytics; 2021 Dec; 23():458-476. PubMed ID: 34901389
[TBL] [Abstract][Full Text] [Related]
31. LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma.
Lin Z; Huang W; Yi Y; Li D; Xie Z; Li Z; Ye M
Int J Gen Med; 2021; 14():8541-8555. PubMed ID: 34849000
[TBL] [Abstract][Full Text] [Related]
32. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
[TBL] [Abstract][Full Text] [Related]
33. The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer.
Ghafouri-Fard S; Hajiesmaeili M; Shoorei H; Bahroudi Z; Taheri M; Sharifi G
Front Cell Dev Biol; 2021; 9():696820. PubMed ID: 34368145
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA LBX2-AS1-modulated miR-4766-5p regulates gastric cancer development through targeting CXCL5.
Peng L; Chen Z; Wang G; Tian S; Kong S; Xu T; An X; Chen Y
Cancer Cell Int; 2020; 20():497. PubMed ID: 33061849
[TBL] [Abstract][Full Text] [Related]
35. LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP.
Wang F; Tang C; Xu D; Tang Y; Jiang Y; Gao X; Xu J
J Cell Mol Med; 2020 Apr; 24(8):4830-4838. PubMed ID: 32160650
[TBL] [Abstract][Full Text] [Related]
36. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
37. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
39. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
[TBL] [Abstract][Full Text] [Related]
40. A review on the role of ADAMTS9-AS2 in different disorders.
Ghafouri-Fard S; Askari A; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2023 Mar; 243():154346. PubMed ID: 36746036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
